Biao Xi has not added Biography.
If you are Biao Xi and would like to personalize this page please email our Author Liaison for assistance.
Live cell quality control and utility of real-time cell electronic sensing for assay development.
Assay and drug development technologies Oct, 2006 | Pubmed ID: 17115925
Dynamic and label-free cell-based assays using the real-time cell electronic sensing system.
Assay and drug development technologies Oct, 2006 | Pubmed ID: 17115930
Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of beta-tubulin at Cys 12 and suppression of microtubule dynamics.
Molecular cancer therapeutics Dec, 2009 | Pubmed ID: 19996274
Rapid and quantitative assessment of cell quality, identity, and functionality for cell-based assays using real-time cellular analysis.
Journal of biomolecular screening Mar, 2011 | Pubmed ID: 21310850
Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment.
British journal of pharmacology Mar, 2012 | Pubmed ID: 21838757
Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System.
Journal of laboratory automation Dec, 2011 | Pubmed ID: 22093298
Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment.
Journal of pharmacological and toxicological methods Sep-Oct, 2016 | Pubmed ID: 27282640
AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients.
Molecular cancer therapeutics 11, 2016 | Pubmed ID: 27573423
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。